Spin-off of GE HealthCare creates global leader in Precision Care GE HealthCare to begin trading on The Nasdaq Stock Market LLC (“Nasdaq”) on January 4, 2023,...
Strong long-term growth prospects as a global leader in precision care post-spin-off from GE Revenue and margin growth drivers: innovation, business optimization, and organic investment Spin...
GE Healthcare announced a $1 million donation of life-saving ultrasound and monitoring equipment to Ukraine as the ongoing war continues to take a heavy toll on the country’s...
DaTscan is first radiopharmaceutical diagnostic tracer approved by U.S. FDA for use in patients with suspected Dementia with Lewy Bodies (DLB) Builds on DaTscan market leadership...